Smith Thomas B 4
4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Feb 14, 2023
Insider Transaction Report
Form 4
Smith Thomas B
EVP and Chief Medical Officer
Transactions
- Award
Common Stock
2023-02-10+31,185→ 31,185 total
Footnotes (1)
- [F1]Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.